AGP Executive Report
Last update: 9 hours agoPsychedelic Therapy Push: Psychedelic-assisted treatments are gaining momentum again, but regulators and trial designs still struggle to keep up after high-profile setbacks. Cancer Care Tech: Foundation Medicine plans to roll out advanced digital tools via Roche’s navify Clinical Hub to speed biomarker-driven treatment decisions at the point of care. Diabetes Device Court Update: A federal appeals court overturned Insulet’s $59M insulin-pump trade secret verdict against EOFlow, citing delays in bringing the case. AI Drug Discovery in Boston: Multiple Boston-area biotech and lab-tech announcements highlight AI-driven, automated chemistry platforms aimed at accelerating small-molecule drug discovery. Public Health & Access: A new look at Massachusetts managed care and Medicare utilization research underscores ongoing pressure points in coverage and transitional care. Community Health Infrastructure: Coverage of Nashoba Valley Medical Center’s closure shows longer ambulance travel times and longer waits for mental health therapy in the region. Heat and Health Risks: Reporting on extreme heat highlights rising heatstroke impacts and growing concern that cities aren’t ready for worsening conditions. Local Safety: Massachusetts updates include guidance on safer e-scooter/e-bike use and ongoing investigation into a trooper struck on I-93.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
